Uploaded February 2026 | Updated September 2026, 2 weeks ago
Highlights:
1. Lilly and NVIDIA are building the world's largest dedicated on-prem biology supercomputer in Indianapolis.
2. A new co-innovation lab built by Lilly and NVIDIA in the Bay Area will unite the brightest minds in computer science and drug discovery to develop foundation models for proteins and cells.
3. How AI-driven protein generation, robotic wet labs, and closed-loop synthetic data will accelerate invention cycles.
4. David Ricks discusses the future of obesity treatments, metabolic health, and the next frontier: tackling dementia and diseases of the aging brain.
5. Jensen Huang explains how the same "digital twin" technology that allows 15,000 engineers to design a chip will soon simulate human biology in silico.
Featured NVIDIA Technology:
1. NVIDIA BioNeMo: nvidia.com/en-us/industries/healthcare-life-sciences/biopharma
Follow us:
X: nvda.ws/4hi2sxB
LinkedIn: nvda.ws/4eSlE3B
Subscribe to the NVIDIA AI Healthcare Newsletter: nvda.ws/4eS1F54
Highlights:
1. Lilly and NVIDIA are building the world's largest dedicated on-prem biology supercomputer in Indianapolis.
2. A new co-innovation lab built by Lilly and NVIDIA in the Bay Area will unite the brightest minds in computer science and drug discovery to develop foundation models for proteins and cells.
3. How AI-driven protein generation, robotic wet labs, and closed-loop synthetic data will accelerate invention cycles.
4. David Ricks discusses the future of obesity treatments, metabolic health, and the next frontier: tackling dementia and diseases of the aging brain.
5. Jensen Huang explains how the same "digital twin" technology that allows 15,000 engineers to design a chip will soon simulate human biology in silico.
Featured NVIDIA Technology:
1. NVIDIA BioNeMo: nvidia.com/en-us/industries/healthcare-life-sciences/biopharma
Follow us:
X: nvda.ws/4hi2sxB
LinkedIn: nvda.ws/4eSlE3B
Subscribe to the NVIDIA AI Healthcare Newsletter: nvda.ws/4eS1F54
